TLSA
Tiziana Life Sciences Ltd
1.10$
-1.8%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
Tiziana Life Sciences Ltd (TLSA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Cost of Revenue" came in at 0.1 million $. Tick rows to compare them in a chart.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q1 25 | Q2 25 | Q3 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.1 | 0.0 | 0.0 | -0.1 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.4 | |
| -0.1 | 0.0 | 0.0 | -0.1 | 0.0 | 0.0 | -0.1 | -0.1 | -0.1 | -0.1 | -0.1 | -0.1 | -0.4 | |
| 6.8 | 5.5 | 3.3 | 4.2 | 4.8 | 4.8 | 5.2 | 5.2 | 2.7 | 3.2 | 3.2 | 7.0 | 16 | |
| 12 | 10.0 | 12 | 15 | 6.2 | 6.2 | 13 | 13 | 9.1 | 8.9 | 8.9 | 12 | 39 | |
| -12 | -10 | -12 | -15 | -6.2 | -6.2 | -13 | -13 | -9.2 | -9.0 | -9.0 | -12 | -39 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | 0.0 | – | – | 0.0 | – | |
| -13 | -11 | -8.6 | -11 | -8.6 | -8.6 | -16 | -16 | -8.8 | -5.6 | -5.6 | -13 | -33 | |
| – | – | – | – | 0.4 | 0.4 | -6.7 | -6.7 | -1.6 | – | – | – | – | |
| -13 | -11 | -8.6 | -11 | -9.1 | -9.1 | -9.3 | -9.3 | -7.2 | -5.6 | -5.6 | -13 | -31 | |
| -13 | -11 | -8.6 | -11 | -8.6 | -8.6 | -16 | -16 | -8.7 | -5.5 | -5.5 | -12 | -32 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.